Please login to the form below
UK Biobank
This page shows the latest UK Biobank news and features for those working in and with pharma, biotech and healthcare.
Novartis plans inclisiran trial in the UK
The Swiss pharma is currently planning a primary prevention study with cholesterol-lowering drug inclisiran in the UK, building on the methods used to recruit patients into the UK Biobank. ... The UK Biobank is a national and international health
Latest news
-
Evotec and Vifor announce joint venture for kidney disease treatments
The discovery of novel nephrology therapeutics will be aided by analysis of clinical data provided by Evotec from the UK kidney biobank NURTuRE.
-
Mistrust of pharma still blocking NHS collaborations
Greater Manchester is leader in breaking down barriers. What’s stopping pharma and the NHS working together more often, and in more parts of the UK? ... The 100, 000 Genomes Project, and the UK Biobank are two leading examples of this, which both sides
-
EMD Serono allies with ‘free sequencing’ firm Nebula
This approach is already being used in the UK Biobank project – backed by a consortium of pharma and biotech companies including Regeneron, AbbVie, Alnylam, AstraZeneca, Biogen, and Pfizer – with data now ... Along with UK Biobank other initiatives
-
UK heart deaths rise for first time in 50 years
But we’re seeing more people die each year from heart and circulatory diseases in the UK before they reach their 75th, or even 65th, birthday. ... genetic data form the UK Biobank to better understand heart disease.
-
UK Biobank generates “largest open access resource of exome data”
genetics research arm Regeneron Genetics Center, will lead a group of pharma companies to complete the exome sequencing of the remaining 450, 000 UK Biobank participants by 2020. ... The data has also allowed the UK Biobank to update a range of other
Evotec and Vifor announce joint venture for kidney disease treatments
Mistrust of pharma still blocking NHS collaborations
EMD Serono allies with ‘free sequencing’ firm Nebula
UK heart deaths rise for first time in 50 years
UK Biobank generates “largest open access resource of exome data”
More from news
Approximately 1 fully matching, plus 10 partially matching documents found.
Latest Intelligence
-
AI and genomics: a revolution in drug discovery and development
in the UK Biobank as an example.
AI and genomics: a revolution in drug discovery and development
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
#DemandDiversity: The science behind diversity
1) It’s been found that Black, Indian, Pakistani and Chinese participants are all underrepresented in the UK Biobank, a huge genetic database, by at least one third. ... And when this is converted to the number of times the data from an individual
#DemandDiversity: The science behind diversity
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Account Manager
-
Competitive Salary
-
Senior Medical Writer
-
Competitive Salary
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
-
Account Management
-
Competitive Salary Offered
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
-
Senior Account Executive
-
Competitive Salary
-
Publications Director
-
Competitive Salary
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
-
Medical Editor
-
Competitive Salary
-
Associate Account Director
-
Competitive Salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Merck & Co reveals plans for women’s health spinoff Organon
- Positive results for GSK/CureVac’s COVID-19 vaccine
- EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19
- Biogen and Capsigen to collaborate on gene therapies
- CanSinoBIO considers booster jab for COVID-19 vaccine
- Research Partnership’s MedTech Division appoints two Directors
- VMLY&Rx launches new payer agency in the US
- Biogen and Envisagenics to advance RNA splicing research for CNS diseases
- Positive results for GSK/CureVac’s COVID-19 vaccine
- New trial data for Keytruda in triple-negative breast cancer
- NICE recommends Keytruda for colorectal cancer patients with rare mutations
- Merck & Co reveals plans for women’s health spinoff Organon
- UK launches subscription-style payment pilot to incentivise pharma antibiotics R&D
- Why female mentorship is so powerful in pharma
- Positive results for GSK/CureVac’s COVID-19 vaccine
- Avoiding A Series of Unfortunate Events: launch lessons from lockdown
- Can protein degraders unlock ‘undruggable’ drug targets?
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- How innovating study sites can improve patient recruitment efficiency
- There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
- Avoiding A Series of Unfortunate Events: launch lessons from lockdown
- Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
- 6 reasons patients drop out of clinical trials and 6 ways to fix it
- If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
